CORDIS - Forschungsergebnisse der EU
CORDIS

Facilitating personalised Lung Treatment Decisions through a Deeptech AI Clinical Decision Support System

Ziel

With the support of EIC funding, Thirona aims to transform their innovative thoracic AI imaging system, LungQ, into an end-to-end clinical decisions support system (CDSS) called LungQ-Care. The current information workflow of thoracic imaging makes it exceedingly complicated to personalise lung treatments. However, LungQ-Care tackles this challenge by enabling radiologists to quantify medical imaging and disease phenotypes to deliver structured analyses to lung doctors. This empowers them to interpret medical imaging effectively and offer personalised treatments to their patients for optimal disease management while reducing costs. LungQ displayed clinical impact by reducing anaesthesia induced bronchoscopic interventions by 81.5% for COPD cases. Additionally, LungQ reduces the time to analyse cystic fibrosis images from days to minutes. With medical and technical expertise, Thirona has the capabilities to lay the foundation for a scalable and ground-breaking AI platform in lung care.

Koordinator

THIRONA BV
Netto-EU-Beitrag
€ 2 499 999,00
Adresse
TOERNOOIVELD 300 MERCATOR 2 GEBOUW
6525EC Nijmegen
Niederlande

Auf der Karte ansehen

KMU

Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen).

Ja
Region
Oost-Nederland Gelderland Arnhem/Nijmegen
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Gesamtkosten
€ 4 756 250,00